July 11, 2019


Veramaris starts commercial delivery of algal oil from US facility




Veramaris has started commercial-scale deliveries from its Blair, Nebraska facility, marking a breakthrough in cultivating marine algae naturally rich in EPA and DHA omega-3 at an unprecedented scale.


(From left) Johann-Caspar Gammelin (Chairman of the Board of Management Evonik Nutrition & Care), Christian Kullmann (CEO Evonik), Neil Leininger (General Manager Veramaris LLC), Nebraska Governor Pete Ricketts, Karim Kurmaly (CEO Veramaris), Frank Beissmann (CFO Veramaris), Feike Sijbesma (CEO DSM), Christoph Goppelsroeder (CEO & President DSM Nutritional Products)
The algal oil enables salmon farmers to become net fish producers (FFDR < 1), while reversing the decade-long decline of EPA & DHA omega-3 levels in salmon. In other words, the aquaculture industry is able to reduce its reliance on the unpredictable forage fisheries facing increasing pressure, and contribute to the United Nations' sustainable development goal.


The US$200 million zero-waste facility was completed in May ahead of schedule, on budget and with zero-accidents. The next step is ramping up for full production.


This unique strain of natural marine algae used, Schizochytrium ssp., is rich in both EPA and DHA, and together with the technology to cultivate it at a very large scale, is a breakthrough that expands the future supply of healthy seafood without impacting ocean resources.


Vermaris' algal oil contains twice as much EPA and DHA as fish oil, so it can reverse the decline in levels of EPA and DHA omega-3 in farmed salmon.


Veramaris' production capacity is equivalent to 1.2 million tonnes of wild-catch fish. This will meet around 15% of the entire salmon farming industry's annual demand for EPA and DHA.


The opening of the new facility was celebrated in the presence of Nebraska Governor Pete Ricketts, local authorities, Feike Sijbesma and Christian Kullmann, the CEOs of the Veramaris parent companies DSM and Evonik.


Read more about Veramaris in this interview with eFeedLink: /contents/05-10-2019/b8591e91-c8ea-4724-b6e0-cd416d586392-a181.html